Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Presentation tomorrow
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(42)
•••
Comment by krikoon Jun 04, 2021 10:35pm
261 Views
Post# 33335324

RE:RE:Presentation tomorrow

RE:RE:Presentation tomorrowActually, this is a bit different than a poster presentation. This is a  Rapid Fire Oral Abstract Session with live Q&A. 

--> Pre-recorded, 5-minute abstract presentations with Live Video Question and Answer at the end of each session.
 
Oral abstracts submitted through the ATC abstract submission process are presented orally with time for questions from the audience at the end of the session. Sessions are designed with specific topic-driven presentations

https://atcmeetingabstracts.com/abstract/islet-allotransplantation-into-pre-vascularized-sernova-cell-pouchtm-preliminary-results-from-the-university-of-chicago/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities